| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 30.47 | -0.28 (-0.91%) | 23.52 - 31.69 | 0.0 |
Market data as of 6:05PM 05/24/13. Quotes are delayed by at least 15 min.
The investment seeks high total return. The fund typically invests directly and indirectly (e.g., through underlying funds or derivatives) in equity securities of companies tied economically to countries other than the U.S., including both developed and emerging countries. It normally invests directly and indirectly at least 80% of its assets in equity investments.
| Total Return | 2.44% |
|---|---|
| Yield (Trailing 12 Mo.) | 3.06% |
| Expense Ratio | 0.49% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $300,000,000 |
| Management Tenure | 11 Years |
| Fund Inception | 03/28/2006 |
| Timeframe | GCEFX | S&P 500 | Foreign Large Value |
|---|---|---|---|
| 1 Month | 6.25% | 1.93% | 4.87% |
| 3 Month | 5.28% | 7.18% | 3.92% |
| Year-to-Date | 9.31% | 12.74% | 8.31% |
| 1 Year | 19.90% | 16.89% | 17.03% |
| 3 Year | 8.36% | 12.80% | 6.02% |
| 5 Year | -0.86% | 5.21% | -1.76% |
| 10 Year | 9.25% | 7.88% | 8.69% |
| Since Inception | 2.44% | 10.38% | -- |
| Basic Materials | 6.66% | |
|---|---|---|
| Consumer Cyclical | 12.08% | |
| Financial Services | 16.30% | |
| Real Estate | 2.43% | |
| Consumer Defensive | 6.76% | |
| Healthcare | 12.33% | |
| Utilities | 6.12% | |
| Communication Services | 9.47% | |
| Energy | 13.38% | |
| Industrials | 10.77% | |
| Technology | 3.69% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 0.00 | 0.00 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.61 | 0.49 | -0.12 | ||
| Foreign Stock | 2.50 | 100.03 | 97.53 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 3.11 | 100.52 | 97.41 | ||
| Cash | 26.93 | 29.52 | 2.59 | ||
| Total Net Assets | $4.71B |
|---|---|
| Total Stock Holdings | 380 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Total SA | -- | 3.77% |
| Sanofi | -- | 2.84% |
| Future Contract On S&P/Tsx 60 Ix Fut Mar13 /Cad/ | -- | 2.50% |
| AstraZeneca PLC | -- | 2.32% |
| BP PLC | 4.81% | 2.31% |
| Banco Santander SA | -10.75% | 2.00% |
| GUSTX | -- | 1.90% |
| Future Contract On Ftse/Mib Idx Fut Mar13 /Eur/ | -- | 1.89% |
| Rio Tinto PLC | -21.57% | 1.76% |
| E. On SE | -2.52% | 1.60% |
| Valuation | GCEFX | Category Range |
|---|---|---|
| Price/Earnings | 10.91 | |
| Price/Book | 1.12 | |
| Price/Sales | 0.49 | |
| Price/Cash Flow | 5.48 | |
| Dividend Yield | 3.91 | |
| LT Earnings | 8.26 | |
| Historical Earnings | 3.34 | |
| Sales Growth | -32.2 | |
| Cash-Flow Growth | -43.5 | |
| Book-Value Growth | -1.21 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Above Avg |
| Pretax Return | 8.36% |
|---|---|
| Tax-adjusted Return | 7.17% |
| Tax Cost Ratio | 1.10% |
| Potential Cap Gains | -11.48% |
